High Expression of NRF2 and Low Expression of KEAP1 Predict Worse Survival in Patients With Operable Triple-Negative Breast Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

High Expression of NRF2 and Low Expression of KEAP1 Predict Worse Survival in Patients With Operable Triple-Negative Breast Cancer

Published:2023 Issue:5 Volume:26 Page:461
ISSN:1738-6756
Container-title:Journal of Breast Cancer
language:en
Short-container-title:J Breast Cancer

Author:

Lee Young Sub¹^ORCID,Kang Jun²^ORCID,Jung Eun Sun¹^ORCID,Lee Ahwon²^ORCID

Affiliation:

1. Department of Hospital Pathology, Eunpyeong St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.

2. Department of Hospital Pathology, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.

Publisher

XMLink

Subject

Cancer Research,Oncology

Link

https://ejbc.kr/pdf/10.4048/jbc.2023.26.e42

Reference38 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2017

3. The Nrf2–Keap1 defence pathway: Role in protection against drug-induced toxicity

4. NRF2 immunolocalization in human breast cancer patients as a prognostic factor

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual role of Nrf2 signaling in hepatocellular carcinoma: promoting development, immune evasion, and therapeutic challenges;Frontiers in Immunology;2024-09-02

2. Tissue- and Temporal-Dependent Dynamics of Myeloablation in Response to Gemcitabine Chemotherapy;Cells;2024-08-07

3. NRF2 activation by cysteine as a survival mechanism for triple-negative breast cancer cells;Oncogene;2024-04-10

4. NRF2 activation by cysteine as a survival mechanism for triple-negative breast cancer cells;2024-01-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3